Matthew D. Landrigan,Krista Toler,Jennifer E. Woodell-May,David L. Suter
申请号：
US15836249
公开号：
US20180099026A1
申请日:
2017.12.08
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Methods of treating peripheral vascular disease comprising administering a protein solution site of a defect at least two proteins from the group IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-β1, and sIL-1RII. The solution may also comprise white blood cells, platelets, concentrated bone marrow aspirate, and combinations thereof.
